LASMIDITAN

LASMIDITAN was reported 1163 times

LASMIDITAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AMPLIFIED MUSCULOSKELETAL PAIN SYNDROME 1 0.0769
1 AMNIOTIC FLUID INDEX INCREASED 1 0.0556
2 VITAMIN B1 INCREASED 1 0.0213
3 BLOOD TESTOSTERONE FREE INCREASED 1 0.0167
4 HYPERPLASIA ADRENAL 1 0.0159
5 AUTOSCOPY 8 0.0148
6 IMPERCEPTION 1 0.0141
7 IMAGING PROCEDURE ABNORMAL 1 0.0100
8 NONREASSURING FOETAL HEART RATE PATTERN 2 0.0090
9 LARYNGOPHARYNGITIS 1 0.0090
10 HYPOTHERMIA NEONATAL 1 0.0070
11 AMNIOTIC FLUID VOLUME INCREASED 1 0.0063
12 COSTOVERTEBRAL ANGLE TENDERNESS 1 0.0061
13 HEMIPLEGIC MIGRAINE 2 0.0059
14 TIME PERCEPTION ALTERED 2 0.0055
15 OBSESSIVE-COMPULSIVE SYMPTOM 2 0.0054
16 MEDICATION OVERUSE HEADACHE 4 0.0047
17 KL-6 INCREASED 1 0.0044
18 BODY MASS INDEX ABNORMAL 1 0.0041
19 VITAMIN B1 DECREASED 1 0.0040
20 ATRIAL ENLARGEMENT 1 0.0037
21 CARDIAC SEPTAL HYPERTROPHY 1 0.0036
22 JOINT LAXITY 1 0.0033
23 TELANGIECTASIA 3 0.0031
24 LOSS OF PROPRIOCEPTION 1 0.0031
25 COLORECTAL ADENOMA 1 0.0031
26 DREAMY STATE 1 0.0031
27 SEDATION 79 0.0030
28 DERMOID CYST 1 0.0030
29 CUBITAL TUNNEL SYNDROME 1 0.0029
30 GASTROINTESTINAL MICROORGANISM OVERGROWTH 1 0.0028
31 INFECTED DERMAL CYST 1 0.0028
32 EUPHORIC MOOD 27 0.0026
33 FAT TISSUE DECREASED 1 0.0026
34 FEELING DRUNK 19 0.0026
35 VISUAL BRIGHTNESS 1 0.0025
36 FEAR OF FALLING 2 0.0025
37 ABULIA 2 0.0022
38 ARTERIOVENOUS FISTULA 1 0.0020
39 DRAINAGE 1 0.0020
40 PRINZMETAL ANGINA 2 0.0020
41 RETROGRADE AMNESIA 1 0.0020
42 ADRENAL ADENOMA 1 0.0017
43 GASTROINTESTINAL BACTERIAL OVERGROWTH 1 0.0017
44 AURA 3 0.0016
45 INTERCEPTED PRODUCT PRESCRIBING ERROR 2 0.0015
46 MAMMOGRAM ABNORMAL 1 0.0015
47 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 2 0.0015
48 OSTEOLYSIS 3 0.0015
49 SEROTONIN SYNDROME 28 0.0015
50 CALCINOSIS 3 0.0013
51 EXTRADURAL ABSCESS 1 0.0013
52 SKULL FRACTURE 2 0.0012
53 ADRENAL MASS 1 0.0012
54 GIANT CELL ARTERITIS 1 0.0012
55 HAEMOCHROMATOSIS 1 0.0011
56 MICROANGIOPATHY 1 0.0011
57 HEMIANOPIA 1 0.0010
58 DRUG EXPOSURE BEFORE PREGNANCY 1 0.0010
59 BREAST ABSCESS 1 0.0010
60 QUADRIPLEGIA 2 0.0010
61 NON-ALCOHOLIC STEATOHEPATITIS 1 0.0010
62 MIGRAINE 89 0.0009
63 SARCOMA 1 0.0009
64 MOANING 1 0.0009
65 HANGOVER 3 0.0009
66 PULMONARY INFARCTION 2 0.0008
67 COCCIDIOIDOMYCOSIS 1 0.0008
68 MAGNETIC RESONANCE IMAGING ABNORMAL 1 0.0008
69 CHRONIC RESPIRATORY FAILURE 1 0.0008
70 MONOCYTE COUNT DECREASED 1 0.0008
71 POST-ACUTE COVID-19 SYNDROME 1 0.0008
72 PRODUCT ADMINISTRATION INTERRUPTED 6 0.0008
73 HYPOVITAMINOSIS 1 0.0008
74 MIGRAINE WITH AURA 2 0.0007
75 SIALOADENITIS 1 0.0007
76 CLUSTER HEADACHE 1 0.0007
77 INFUSION SITE RASH 1 0.0007
78 ELECTRIC SHOCK SENSATION 2 0.0007
79 TONIC CONVULSION 1 0.0007
80 OBSTRUCTIVE SLEEP APNOEA SYNDROME 1 0.0007
81 NEGATIVE THOUGHTS 2 0.0007
82 FEELING OF BODY TEMPERATURE CHANGE 4 0.0007
83 CONJUNCTIVITIS ALLERGIC 1 0.0007
84 SECONDARY ADRENOCORTICAL INSUFFICIENCY 1 0.0007
85 RUBBER SENSITIVITY 1 0.0007
86 DAYDREAMING 1 0.0006
87 POLYCYSTIC OVARIES 1 0.0006
88 HYPOGLYCAEMIA NEONATAL 1 0.0006
89 OXYGEN THERAPY 1 0.0006
90 VENA CAVA THROMBOSIS 1 0.0006
91 VEIN RUPTURE 1 0.0006
92 DYSPHORIA 3 0.0006
93 EROSIVE OESOPHAGITIS 1 0.0006
94 HALLUCINATION 44 0.0006
95 TACHYPHRENIA 2 0.0006
96 LACK OF INJECTION SITE ROTATION 1 0.0006
97 DRUG SCREEN NEGATIVE 1 0.0006
98 HALLUCINATION, VISUAL 12 0.0006
99 PRODUCT TAMPERING 1 0.0006
100 ESSENTIAL HYPERTENSION 1 0.0005
101 ABNORMAL DREAMS 15 0.0005
102 SOMNOLENCE 109 0.0005
103 DENTAL CARE 1 0.0005
104 DRUG EFFECT LESS THAN EXPECTED 8 0.0005
105 HYPERTRICHOSIS 1 0.0005
106 HYPERACUSIS 2 0.0005
107 NEURODERMATITIS 2 0.0005
108 TUNNEL VISION 1 0.0005
109 THROAT CLEARING 2 0.0005
110 IMPAIRED DRIVING ABILITY 6 0.0005
111 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
112 PANIC DISORDER 2 0.0005
113 CONVERSION DISORDER 1 0.0005
114 THERAPEUTIC PRODUCT EFFECT VARIABLE 2 0.0005
115 JOINT NOISE 1 0.0005
116 FEELING ABNORMAL 118 0.0005
117 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 1 0.0005
118 HALLUCINATIONS, MIXED 2 0.0005
119 DEREALISATION 1 0.0005
120 TEMPERATURE REGULATION DISORDER 1 0.0004
121 CHRONIC GASTRITIS 1 0.0004
122 READING DISORDER 1 0.0004
123 ORAL PRURITUS 1 0.0004
124 MUSCLE TWITCHING 10 0.0004
125 FORMICATION 3 0.0004
126 NECK SURGERY 1 0.0004
127 ORAL SURGERY 1 0.0004
128 DIZZINESS 210 0.0004
129 PANIC REACTION 3 0.0004
130 SLOW SPEECH 1 0.0004
131 PANIC ATTACK 15 0.0004
132 VENTRICULAR EXTRASYSTOLES 4 0.0004
133 NASAL DISORDER 1 0.0004
134 YAWNING 1 0.0004
135 BRUXISM 2 0.0004
136 PARAESTHESIA 58 0.0004
137 THERAPEUTIC RESPONSE DELAYED 1 0.0004
138 FACIAL PARALYSIS 3 0.0004
139 HYPERSOMNIA 10 0.0003
140 PARAESTHESIA ORAL 5 0.0003
141 PULMONARY PAIN 1 0.0003
142 DEVICE POWER SOURCE ISSUE 1 0.0003
143 LUMBAR SPINAL STENOSIS 1 0.0003
144 HYPOAESTHESIA ORAL 5 0.0003
145 RESTLESS LEGS SYNDROME 6 0.0003
146 TENSION 2 0.0003
147 FEELING JITTERY 6 0.0003
148 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2 0.0003
149 PEPTIC ULCER 1 0.0003
150 MATERNAL EXPOSURE BEFORE PREGNANCY 2 0.0003
151 HYPERREFLEXIA 1 0.0003
152 LOGORRHOEA 1 0.0003
153 PARALYSIS 4 0.0003
154 PYODERMA GANGRENOSUM 1 0.0003
155 DISORIENTATION 11 0.0003
156 SKIN LACERATION 3 0.0003
157 SPONDYLITIS 1 0.0003
158 WOUND INFECTION 3 0.0003
159 THERAPEUTIC RESPONSE SHORTENED 9 0.0003
160 LOSS OF CONTROL OF LEGS 1 0.0003
161 THYROID MASS 1 0.0003
162 BRAIN FOG 4 0.0003
163 DRUG SCREEN POSITIVE 2 0.0003
164 MYOCLONUS 3 0.0003
165 TRIGEMINAL NEURALGIA 1 0.0002
166 ENURESIS 1 0.0002
167 FRUSTRATION TOLERANCE DECREASED 2 0.0002
168 HOMICIDAL IDEATION 1 0.0002
169 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
170 SPINAL FUSION SURGERY 1 0.0002
171 SUICIDAL BEHAVIOUR 1 0.0002
172 MUSCLE FATIGUE 1 0.0002
173 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
174 INFUSION SITE PAIN 3 0.0002
175 PARANOIA 4 0.0002
176 HEAD DISCOMFORT 4 0.0002
177 CATHETERISATION CARDIAC 1 0.0002
178 MENINGITIS ASEPTIC 1 0.0002
179 IMPAIRED GASTRIC EMPTYING 3 0.0002
180 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
181 INCREASED TENDENCY TO BRUISE 2 0.0002
182 PHOTOPHOBIA 4 0.0002
183 DYSARTHRIA 8 0.0002
184 SEASONAL ALLERGY 3 0.0002
185 SARCOIDOSIS 1 0.0002
186 ENDOMETRIOSIS 1 0.0002
187 HYPOAESTHESIA 31 0.0002
188 MENTAL IMPAIRMENT 5 0.0002
189 HORMONE LEVEL ABNORMAL 1 0.0002
190 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
191 INFLAMMATORY BOWEL DISEASE 2 0.0002
192 BREATH SOUNDS ABNORMAL 1 0.0002
193 NIGHTMARE 7 0.0002
194 FLUID INTAKE REDUCED 1 0.0002
195 VEIN DISORDER 1 0.0002
196 ENDOCARDITIS 1 0.0002
197 INITIAL INSOMNIA 2 0.0002
198 TRISMUS 1 0.0002
199 MALABSORPTION 1 0.0002
200 NYSTAGMUS 1 0.0002
201 FOOD POISONING 1 0.0002
202 GASTROINTESTINAL PAIN 2 0.0002
203 CHOKING SENSATION 1 0.0002
204 VERTIGO 11 0.0002
205 HEART RATE ABNORMAL 1 0.0002
206 EYE INFECTION 2 0.0002
207 PERIORBITAL SWELLING 1 0.0002
208 DERMATITIS CONTACT 2 0.0002
209 NEUROLOGICAL SYMPTOM 1 0.0002
210 CARDIAC VALVE DISEASE 1 0.0002
211 EXERCISE TOLERANCE DECREASED 1 0.0002
212 MOUTH SWELLING 1 0.0002
213 RALES 1 0.0002
214 SKIN WARM 1 0.0002
215 HEART RATE INCREASED 17 0.0002
216 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
217 ENERGY INCREASED 1 0.0002
218 LIMB DISCOMFORT 5 0.0002
219 INFUSION SITE SWELLING 1 0.0002
220 MUSCULAR WEAKNESS 18 0.0002
221 PHOTOPSIA 1 0.0002
222 THERAPEUTIC RESPONSE CHANGED 1 0.0002
223 THROAT IRRITATION 7 0.0002
224 MYDRIASIS 2 0.0002
225 ILLNESS 16 0.0002
226 CARDIAC FLUTTER 1 0.0002
227 DYSTONIA 3 0.0002
228 INCOHERENT 1 0.0002
229 HIATUS HERNIA 2 0.0002
230 TENDON DISORDER 1 0.0002
231 SPEECH DISORDER 8 0.0002
232 BALANCE DISORDER 13 0.0002
233 COGNITIVE DISORDER 7 0.0001
234 SKIN MASS 1 0.0001
235 MENINGITIS 1 0.0001
236 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
237 ULCER HAEMORRHAGE 1 0.0001
238 DISCOMFORT 9 0.0001
239 PERIPHERAL COLDNESS 2 0.0001
240 JOINT EFFUSION 1 0.0001
241 DROOLING 1 0.0001
242 COORDINATION ABNORMAL 2 0.0001
243 RIGHT VENTRICULAR FAILURE 1 0.0001
244 HEART RATE DECREASED 5 0.0001
245 HYPOKINESIA 2 0.0001
246 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
247 MAJOR DEPRESSION 1 0.0001
248 SENSITIVE SKIN 1 0.0001
249 SUNBURN 1 0.0001
250 KETOACIDOSIS 1 0.0001
251 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
252 TREMOR 22 0.0001
253 HYPERTHERMIA 1 0.0001
254 TINNITUS 6 0.0001
255 DISSOCIATION 1 0.0001
256 PALPITATIONS 15 0.0001
257 NASAL DISCOMFORT 1 0.0001
258 RESPIRATORY TRACT CONGESTION 2 0.0001
259 HALLUCINATION, AUDITORY 2 0.0001
260 MOBILITY DECREASED 9 0.0001
261 SENSORY DISTURBANCE 2 0.0001
262 RHINITIS 1 0.0001
263 MYASTHENIA GRAVIS 1 0.0001
264 MUSCLE TIGHTNESS 2 0.0001
265 PRESYNCOPE 3 0.0001
266 NEURALGIA 3 0.0001
267 AGITATION 9 0.0001
268 INJECTION SITE URTICARIA 3 0.0001
269 LETHARGY 7 0.0001
270 MANIA 2 0.0001
271 EXPIRED PRODUCT ADMINISTERED 4 0.0001
272 HEMIPLEGIA 1 0.0001
273 EOSINOPHIL COUNT INCREASED 1 0.0001
274 LIVE BIRTH 1 0.0001
275 CHEST DISCOMFORT 12 0.0001
276 PSEUDOMONAS INFECTION 1 0.0001
277 GASTRIC DISORDER 4 0.0001
278 INSOMNIA 31 0.0001
279 SPINAL OSTEOARTHRITIS 1 0.0001
280 DRUG ERUPTION 2 0.0001
281 FACIAL PAIN 1 0.0001
282 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
283 THERAPY NON-RESPONDER 5 0.0001
284 OROPHARYNGEAL DISCOMFORT 1 0.0001
285 CRYING 4 0.0001
286 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2 0.0001
287 NAUSEA 86 0.0001
288 OVARIAN CANCER 1 0.0001
289 IRON DEFICIENCY ANAEMIA 1 0.0001
290 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
291 FEELING COLD 3 0.0001
292 FLANK PAIN 1 0.0001
293 HEADACHE 66 0.0001
294 PRODUCT PACKAGING ISSUE 1 0.0001
295 INTENTIONAL DOSE OMISSION 3 0.0001
296 POST PROCEDURAL COMPLICATION 2 0.0001
297 LOWER LIMB FRACTURE 2 0.0001
298 DRUG INEFFECTIVE 137 0.0001
299 HYPERCHOLESTEROLAEMIA 1 0.0001
300 DIZZINESS POSTURAL 1 0.0001
301 VITAMIN D DEFICIENCY 1 0.0001
302 NASAL CONGESTION 6 0.0001
303 VITREOUS FLOATERS 1 0.0001
304 SALIVARY HYPERSECRETION 1 0.0001
305 BRAIN INJURY 1 0.0001
306 EMPHYSEMA 1 0.0001
307 DYSKINESIA 4 0.0001
308 EYELID PTOSIS 1 0.0001
309 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 7 0.0001
310 SUBARACHNOID HAEMORRHAGE 1 0.0001
311 MOTOR DYSFUNCTION 1 0.0001
312 SLUGGISHNESS 1 0.0001
313 FEELING HOT 6 0.0001
314 COVID-19 17 0.0001
315 POOR VENOUS ACCESS 1 0.0001
316 WEIGHT FLUCTUATION 1 0.0001
317 SEIZURE 11 0.0001
318 INJECTION SITE DISCOMFORT 1 0.0001
319 JOINT DISLOCATION 1 0.0001
320 JOINT INJURY 2 0.0001
321 HEREDITARY ANGIOEDEMA 1 0.0001
322 POOR QUALITY SLEEP 2 0.0001
323 DISTURBANCE IN ATTENTION 5 0.0001
324 PHARYNGITIS STREPTOCOCCAL 1 0.0001
325 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
326 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
327 PULMONARY THROMBOSIS 1 0.0001
328 ANXIETY 26 0.0001
329 HYPERTENSIVE CRISIS 1 0.0001
330 NECK PAIN 5 0.0001
331 MALNUTRITION 1 0.0001
332 GAIT DISTURBANCE 17 0.0001
333 MYOCARDIAL ISCHAEMIA 1 0.0001
334 MEMORY IMPAIRMENT 12 0.0001
335 FATIGUE 68 0.0001
336 MADAROSIS 1 0.0001
337 CAESAREAN SECTION 1 0.0001
338 VASCULITIS 1 0.0001
339 SEXUAL DYSFUNCTION 1 0.0001
340 SURGERY 5 0.0001
341 ATAXIA 1 0.0001
342 PRODUCT PRESCRIBING ERROR 2 0.0001
343 ACCIDENT 1 0.0001
344 IRRITABILITY 5 0.0001
345 THERAPEUTIC RESPONSE DECREASED 5 0.0001
346 FIBROMYALGIA 2 0.0001
347 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
348 SPINAL OPERATION 1 0.0001
349 HYPERCALCAEMIA 1 0.0001
350 VISUAL IMPAIRMENT 10 0.0001
351 TOOTH EXTRACTION 1 0.0001
352 DYSPNOEA EXERTIONAL 3 0.0001
353 DERMATITIS ALLERGIC 1 0.0001
354 HAEMATEMESIS 2 0.0001
355 HYPOPHAGIA 2 0.0001
356 EXPOSURE VIA SKIN CONTACT 2 0.0001
357 JOINT RANGE OF MOTION DECREASED 1 0.0001
358 FEAR 2 0.0001
359 SINUS CONGESTION 1 0.0001
360 LIMB INJURY 2 0.0001
361 CORONARY ARTERY OCCLUSION 1 0.0001
362 WOUND 2 0.0001
363 BURNING SENSATION 5 0.0001
364 SLEEP DISORDER 5 0.0001
365 PAIN IN JAW 2 0.0001
366 LOSS OF CONSCIOUSNESS 9 0.0001
367 ANGINA PECTORIS 2 0.0001
368 MENTAL DISORDER 3 0.0001
369 GASTROENTERITIS 1 0.0001
370 SKIN HAEMORRHAGE 1 0.0001
371 PULMONARY MASS 1 0.0001
372 APHASIA 2 0.0001
373 SUICIDAL IDEATION 6 0.0001
374 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
375 EMOTIONAL DISORDER 2 0.0001
376 TENDONITIS 1 0.0001
377 THERAPY PARTIAL RESPONDER 1 0.0001
378 HEAD INJURY 2 0.0001
379 PNEUMOTHORAX 1 0.0001
380 SCIATICA 1 0.0001
381 ABSCESS 1 0.0001
382 DRUG INTOLERANCE 6 0.0001
383 RHINORRHOEA 4 0.0001
384 BACK DISORDER 1 0.0001
385 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 11 0.0001
386 PHOTOSENSITIVITY REACTION 1 0.0001
387 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
388 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
389 BLOOD PRESSURE DECREASED 4 0.0001
390 VIRAL INFECTION 2 0.0001
391 COAGULOPATHY 1 0.0001
392 GAIT INABILITY 2 0.0001
393 ABDOMINAL DISCOMFORT 10 0.0001
394 FACE OEDEMA 1 0.0001
395 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
396 HEMIPARESIS 1 0.0001
397 CEREBROVASCULAR ACCIDENT 10 0.0001
398 ORTHOSTATIC HYPOTENSION 1 0.0001
399 NERVOUSNESS 3 0.0001
400 DEVICE USE ISSUE 1 0.0001
401 FALL 19 0.0001
402 MALAISE 25 0.0001
403 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
404 BRADYCARDIA 3 0.0001
405 ISCHAEMIC STROKE 1 0.0001
406 COMPLICATION OF DEVICE REMOVAL 1 0.0001
407 VOMITING 26 0.0001
408 TREATMENT NONCOMPLIANCE 3 0.0001
409 RESTLESSNESS 2 0.0001
410 HYPERHIDROSIS 7 0.0001
411 CONJUNCTIVITIS 1 0.0001
412 HEPATIC STEATOSIS 1 0.0001
413 THINKING ABNORMAL 1 0.0001
414 MIDDLE INSOMNIA 1 0.0001
415 EPISTAXIS 4 0.0001
416 BLOOD PRESSURE INCREASED 8 0.0001
417 EYE IRRITATION 3 0.0001
418 PRESCRIBED OVERDOSE 1 0.0001
419 EAR PAIN 1 0.0001
420 HAEMORRHOIDS 1 0.0001
421 ORAL HERPES 1 0.0001
422 DISABILITY 1 0.0001
423 SINUS DISORDER 1 0.0001
424 BLOOD PRESSURE ABNORMAL 1 0.0001
425 UPPER LIMB FRACTURE 1 0.0001
426 PRODUCT PHYSICAL ISSUE 1 0.0000
427 FEEDING DISORDER 1 0.0000
428 FLUSHING 5 0.0000
429 INJURY ASSOCIATED WITH DEVICE 1 0.0000
430 BODY TEMPERATURE INCREASED 1 0.0000
431 PULMONARY HYPERTENSION 1 0.0000
432 WITHDRAWAL SYNDROME 2 0.0000
433 KNEE ARTHROPLASTY 1 0.0000
434 FAECES DISCOLOURED 1 0.0000
435 SWELLING FACE 3 0.0000
436 DEVICE DIFFICULT TO USE 3 0.0000
437 GLOSSODYNIA 1 0.0000
438 SNEEZING 1 0.0000
439 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 9 0.0000
440 CHROMATURIA 1 0.0000
441 HEART RATE IRREGULAR 1 0.0000
442 MUSCLE SPASMS 8 0.0000
443 ADVERSE EVENT 4 0.0000
444 CONFUSIONAL STATE 7 0.0000
445 CHEST PAIN 8 0.0000
446 THERAPY INTERRUPTED 3 0.0000
447 RASH ERYTHEMATOUS 2 0.0000
448 MULTIPLE SCLEROSIS 2 0.0000
449 BLOOD PRESSURE FLUCTUATION 1 0.0000
450 BLOOD GLUCOSE DECREASED 2 0.0000
451 UNDERDOSE 3 0.0000
452 CEREBRAL INFARCTION 1 0.0000
453 DYSGEUSIA 3 0.0000
454 DRY EYE 2 0.0000
455 CELLULITIS 2 0.0000
456 ABDOMINAL PAIN LOWER 1 0.0000
457 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
458 ANAPHYLACTIC SHOCK 1 0.0000
459 DIPLOPIA 1 0.0000
460 RESPIRATORY TRACT INFECTION 1 0.0000
461 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
462 DRUG DOSE OMISSION BY DEVICE 3 0.0000
463 DEAFNESS 1 0.0000
464 GASTRITIS 1 0.0000
465 DEPRESSED MOOD 2 0.0000
466 EAR INFECTION 1 0.0000
467 THROAT TIGHTNESS 1 0.0000
468 OEDEMA 2 0.0000
469 MOOD ALTERED 1 0.0000
470 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
471 PRURITUS 14 0.0000
472 VISION BLURRED 5 0.0000
473 TREATMENT FAILURE 3 0.0000
474 DIVERTICULITIS 1 0.0000
475 PROCEDURAL PAIN 1 0.0000
476 INJECTION SITE PAIN 11 0.0000
477 COUGH 10 0.0000
478 DEPRESSION 8 0.0000
479 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
480 NEEDLE ISSUE 1 0.0000
481 CHILLS 4 0.0000
482 PSYCHOTIC DISORDER 1 0.0000
483 TACHYCARDIA 3 0.0000
484 URINARY INCONTINENCE 1 0.0000
485 ADVERSE DRUG REACTION 3 0.0000
486 BLOOD POTASSIUM DECREASED 1 0.0000
487 NO ADVERSE EVENT 6 0.0000
488 LACRIMATION INCREASED 1 0.0000
489 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
490 EPILEPSY 1 0.0000
491 INJECTION SITE RASH 1 0.0000
492 NASOPHARYNGITIS 6 0.0000
493 OROPHARYNGEAL PAIN 3 0.0000
494 HYPERSENSITIVITY 6 0.0000
495 FEMUR FRACTURE 1 0.0000
496 SWELLING 3 0.0000
497 PULMONARY EMBOLISM 3 0.0000
498 HYPOTHYROIDISM 1 0.0000
499 MOVEMENT DISORDER 1 0.0000
500 ATRIAL FIBRILLATION 3 0.0000
501 BLOOD CREATININE INCREASED 2 0.0000
502 OSTEONECROSIS 1 0.0000
503 EYE DISORDER 1 0.0000
504 STAPHYLOCOCCAL INFECTION 1 0.0000
505 URTICARIA 5 0.0000
506 EYE PRURITUS 1 0.0000
507 HEPATIC ENZYME INCREASED 2 0.0000
508 ASTHENIA 11 0.0000
509 ABDOMINAL DISTENSION 3 0.0000
510 MYOCARDIAL INFARCTION 5 0.0000
511 INFECTION 4 0.0000
512 CONSTIPATION 6 0.0000
513 C-REACTIVE PROTEIN INCREASED 1 0.0000
514 HYPERGLYCAEMIA 1 0.0000
515 INJECTION SITE MASS 1 0.0000
516 BRONCHITIS 2 0.0000
517 EYE SWELLING 1 0.0000
518 ASTHMA 3 0.0000
519 HOT FLUSH 2 0.0000
520 INTESTINAL OBSTRUCTION 1 0.0000
521 DYSPNOEA 15 0.0000
522 DIABETES MELLITUS 2 0.0000
523 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
524 HOSPITALISATION 4 0.0000
525 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
526 ABNORMAL BEHAVIOUR 1 0.0000
527 DRUG INTERACTION 4 0.0000
528 ABORTION SPONTANEOUS 1 0.0000
529 THROMBOSIS 2 0.0000
530 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
531 PSORIATIC ARTHROPATHY 1 0.0000
532 DEVICE BREAKAGE 1 0.0000
533 ABDOMINAL PAIN UPPER 5 0.0000
534 PRODUCT USE IN UNAPPROVED INDICATION 6 0.0000
535 INJECTION SITE ERYTHEMA 3 0.0000
536 RHABDOMYOLYSIS 1 0.0000
537 ROAD TRAFFIC ACCIDENT 1 0.0000
538 RENAL IMPAIRMENT 2 0.0000
539 HYPERTENSION 5 0.0000
540 OSTEOARTHRITIS 1 0.0000
541 MYALGIA 4 0.0000
542 HYPOACUSIS 1 0.0000
543 DEVICE DISLOCATION 1 0.0000
544 INTENTIONAL PRODUCT MISUSE 2 0.0000
545 PAIN 14 0.0000
546 ANGIOEDEMA 1 0.0000
547 WEIGHT INCREASED 5 0.0000
548 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
549 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
550 NEPHROLITHIASIS 1 0.0000
551 SKIN DISCOLOURATION 1 0.0000
552 OFF LABEL USE 19 0.0000
553 DIARRHOEA 14 0.0000
554 RENAL DISORDER 1 0.0000
555 BLOOD CHOLESTEROL INCREASED 1 0.0000
556 ARRHYTHMIA 1 0.0000
557 DYSPHAGIA 2 0.0000
558 PRODUCTIVE COUGH 1 0.0000
559 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
560 HYPOGLYCAEMIA 1 0.0000
561 CONDITION AGGRAVATED 6 0.0000
562 FLUID RETENTION 1 0.0000
563 SINUSITIS 2 0.0000
564 PERIPHERAL SWELLING 3 0.0000
565 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
566 INFLAMMATION 1 0.0000
567 HAEMORRHAGE 2 0.0000
568 ECZEMA 1 0.0000
569 ARTHROPATHY 1 0.0000
570 INFLUENZA 2 0.0000
571 SEPSIS 2 0.0000
572 OXYGEN SATURATION DECREASED 1 0.0000
573 PRODUCT SUBSTITUTION ISSUE 1 0.0000
574 DECREASED APPETITE 4 0.0000
575 BACK PAIN 4 0.0000
576 PAIN IN EXTREMITY 5 0.0000
577 WHEEZING 1 0.0000
578 CATARACT 1 0.0000
579 SUICIDE ATTEMPT 1 0.0000
580 OEDEMA PERIPHERAL 2 0.0000
581 INTENTIONAL OVERDOSE 1 0.0000
582 AMNESIA 1 0.0000
583 INFUSION RELATED REACTION 1 0.0000
584 NEOPLASM MALIGNANT 1 0.0000
585 INJECTION SITE PRURITUS 1 0.0000
586 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
587 WEIGHT DECREASED 4 0.0000
588 DEVICE MALFUNCTION 1 0.0000
589 INJURY 1 0.0000
590 RASH 6 0.0000
591 RESPIRATORY FAILURE 1 0.0000
592 PRODUCT DOSE OMISSION ISSUE 4 0.0000
593 UNEVALUABLE EVENT 1 0.0000
594 ARTHRITIS 1 0.0000
595 INJECTION SITE BRUISING 1 0.0000
596 CARDIAC FAILURE CONGESTIVE 1 0.0000
597 PNEUMONIA 4 0.0000
598 DRY MOUTH 1 0.0000
599 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
600 INFLUENZA LIKE ILLNESS 1 0.0000
601 ARTHRALGIA 5 0.0000
602 URINARY TRACT INFECTION 2 0.0000
603 DEATH 10 0.0000
604 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
605 CONTUSION 1 0.0000
606 DYSPEPSIA 1 0.0000
607 SYNCOPE 1 0.0000
608 HYPOTENSION 2 0.0000
609 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
610 RHEUMATOID ARTHRITIS 1 0.0000
611 PYREXIA 3 0.0000
612 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
613 ABDOMINAL PAIN 2 0.0000
614 DISEASE PROGRESSION 1 0.0000
615 JOINT SWELLING 1 0.0000
616 RENAL FAILURE 1 0.0000
617 ACUTE KIDNEY INJURY 1 0.0000
618 DRUG DEPENDENCE 1 0.0000
619 TOXICITY TO VARIOUS AGENTS 1 0.0000
620 PRODUCT USE ISSUE 1 0.0000
621 BLOOD GLUCOSE INCREASED 1 0.0000
622 ALOPECIA 1 0.0000
623 OVERDOSE 1 0.0000
624 INCORRECT DOSE ADMINISTERED 1 0.0000